McKesson Corporation (MCK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, McKesson Corporation (MCK) has a cash flow conversion efficiency ratio of 0.057x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-220.00 Million) by net assets ($-3.86 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see McKesson Corporation market capitalisation for the company's overall valuation and market capitalisation.
McKesson Corporation - Cash Flow Conversion Efficiency Trend (1995–2026)
This chart illustrates how McKesson Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.
McKesson Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of McKesson Corporation ranked by their cash flow conversion efficiency. Explore cash flow quality index of McKesson Corporation to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
UBS Group AG
SW:UBSG
|
-0.043x |
|
Agnico Eagle Mines Limited
TO:AEM
|
0.073x |
|
Cambricon Technologies Corp Ltd
SHG:688256
|
-0.034x |
|
Pinduoduo Inc
F:9PDA
|
0.039x |
|
GSK PLC SP. ADR/2 NEW
F:GS70
|
0.157x |
|
China Yangtze Power Co Ltd
SHG:600900
|
0.084x |
|
Air Liquide SA
PA:AI
|
0.130x |
|
CVS Health Corp
NYSE:CVS
|
0.045x |
Annual Cash Flow Conversion Efficiency for McKesson Corporation (1995–2026)
The table below shows the annual cash flow conversion efficiency of McKesson Corporation from 1995 to 2026. View McKesson Corporation stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | $-834.00 Million | $6.16 Billion | -7.380x | -105.45% |
| 2025-03-31 | $-1.69 Billion | $6.08 Billion | -3.592x | -33.14% |
| 2024-03-31 | $-1.60 Billion | $4.31 Billion | -2.698x | +22.08% |
| 2023-03-31 | $-1.49 Billion | $5.16 Billion | -3.462x | -39.93% |
| 2022-03-31 | $-1.79 Billion | $4.43 Billion | -2.474x | -178.77% |
| 2021-03-31 | $1.45 Billion | $4.54 Billion | 3.141x | +381.93% |
| 2020-03-31 | $6.71 Billion | $4.37 Billion | 0.652x | +56.32% |
| 2019-03-31 | $9.68 Billion | $4.04 Billion | 0.417x | +10.51% |
| 2018-03-31 | $11.52 Billion | $4.34 Billion | 0.377x | +0.21% |
| 2017-03-31 | $12.60 Billion | $4.74 Billion | 0.377x | +6.78% |
| 2016-03-31 | $10.41 Billion | $3.67 Billion | 0.353x | +7.31% |
| 2015-03-31 | $9.47 Billion | $3.11 Billion | 0.329x | +8.11% |
| 2014-03-31 | $10.32 Billion | $3.14 Billion | 0.304x | -13.46% |
| 2013-03-31 | $7.07 Billion | $2.48 Billion | 0.351x | -18.68% |
| 2012-03-31 | $6.83 Billion | $2.95 Billion | 0.432x | +33.36% |
| 2011-03-31 | $7.22 Billion | $2.34 Billion | 0.324x | +5.31% |
| 2010-03-31 | $7.53 Billion | $2.32 Billion | 0.307x | +40.95% |
| 2009-03-31 | $6.19 Billion | $1.35 Billion | 0.218x | +53.66% |
| 2008-03-31 | $6.12 Billion | $869.00 Million | 0.142x | -42.13% |
| 2007-03-31 | $6.27 Billion | $1.54 Billion | 0.245x | -47.19% |
| 2006-03-31 | $5.91 Billion | $2.74 Billion | 0.465x | +59.29% |
| 2005-03-31 | $5.28 Billion | $1.54 Billion | 0.292x | +167.37% |
| 2004-03-31 | $5.17 Billion | $563.40 Million | 0.109x | -25.90% |
| 2003-03-31 | $4.72 Billion | $695.50 Million | 0.147x | +84.89% |
| 2002-03-31 | $4.14 Billion | $329.30 Million | 0.080x | -16.83% |
| 2001-03-31 | $3.69 Billion | $353.10 Million | 0.096x | +186.55% |
| 2000-03-31 | $3.76 Billion | $-416.00 Million | -0.111x | -207.33% |
| 1999-03-31 | $3.08 Billion | $317.10 Million | 0.103x | +7404.23% |
| 1998-03-31 | $1.60 Billion | $2.20 Million | 0.001x | -99.16% |
| 1997-03-31 | $1.46 Billion | $238.10 Million | 0.164x | +7239.94% |
| 1996-03-31 | $1.12 Billion | $2.50 Million | 0.002x | -98.77% |
| 1995-03-31 | $1.07 Billion | $195.10 Million | 0.182x | -- |
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; d… Read more